BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21519005)

  • 1. Increasing incidence of myasthenia gravis among elderly in British Columbia, Canada.
    Pakzad Z; Aziz T; Oger J
    Neurology; 2011 Apr; 76(17):1526-8. PubMed ID: 21519005
    [No Abstract]   [Full Text] [Related]  

  • 2. Lifetime course of myasthenia gravis.
    Grob D; Brunner N; Namba T; Pagala M
    Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositive myasthenia gravis: a nationwide epidemiologic study.
    Heldal AT; Owe JF; Gilhus NE; Romi F
    Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis and elderly people.
    Schon F; Drayson M; Thompson RA
    Age Ageing; 1996 Jan; 25(1):56-8. PubMed ID: 8670530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis and other neuromuscular junction disorders.
    Jacob S; Viegas S; Lashley D; Hilton-Jones D
    Pract Neurol; 2009 Dec; 9(6):364-71. PubMed ID: 19923120
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
    Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
    Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
    Jitpimolmard S; Taimkao S; Chotmongkol V; Sawanyawisuth K; Vincent A; Newsom-Davis J
    J Med Assoc Thai; 2006 Jan; 89(1):68-71. PubMed ID: 16583584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
    Somnier FE
    Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up study of anti-acetylcholine receptor antibody titers and clinical symptoms in patients with myasthenia gravis].
    Komiya T; Sato T
    Rinsho Shinkeigaku; 1988 Jul; 28(7):727-34. PubMed ID: 3233845
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis and recurrent falls in an elderly patient.
    Chua E; McLoughlin C; Sharma AK
    Age Ageing; 2000 Jan; 29(1):83-4. PubMed ID: 10690702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine receptor antibody positive generalized myasthenia gravis in association with primary biliary cirrhosis.
    Taddy H; Yoshida EM; Gibson G; Chatur N
    Ann Hepatol; 2010; 9(4):471-2. PubMed ID: 21057170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-AChR-negative myasthenia gravis: clinical and immunological features.
    Evoli A; Bartoccioni E; Batocchi AP; Scuderi F; Tonali P
    Clin Invest Med; 1989 Apr; 12(2):104-9. PubMed ID: 2706833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis. Laboratory and clinical analysis of 120 cases.
    Xu XH
    Chin Med J (Engl); 1986 Jul; 99(7):555-60. PubMed ID: 3100203
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.
    Bedlack RS; Simel DL; Bosworth H; Samsa G; Tucker-Lipscomb B; Sanders DB
    Neurology; 2005 Jun; 64(11):1968-70. PubMed ID: 15955957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
    Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MuSK-antibody positive myasthenia gravis: questions from the clinic.
    Sanders DB; Juel VC
    J Neuroimmunol; 2008 Sep; 201-202():85-9. PubMed ID: 18684517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.